Keltsev V.

Ostatnio edytowane

1. Pharmacokinetics (PK) and pharmacodynamics (PD) of tocilizumab (TCZ) in polyarticular-course juvenile idiopathic arthritis (pcJIA). [AUT.] X. ZHANG, J. HSU, H. BRUNNER, F. DE BENEDETTI, C. LE GALLO, Z. ZUBER, R. CUTTICA, V. KELTSEV, R. XAVIER, I. C. PENEDES, N. RUBIO-PÉREZ, V. CHASNYK, G. HORNEFF, V[IOLETTA] OPOKA-WINIARSKA, P. QUARTIER, C. SILVA, A. SPINDLER, E. BAILDAM, M. L. GAMIR, A. MARTIN, D. A. SIRI, E. SMOLEWSKA, D. LOVELL, N. RUPERTO, A. MARTINI. Clin. Pharmacol. Ther. 2013 vol. 93 nr S1 s. S88-S89, Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) : Quantitative systems pharmacology an integrating framework for translational medicine pre-conference. Indianapolis, March, 05-09, 2013. [Abstr.]. DOI: 10.1038/clpt.2012.258
2. Efficacy and safety of tocilizumab in patients with polyarticular juvenile idiopathic arthritis: data from a phase 3 trial. [AUT.] F. DE BENEDETTI, N. RUPERTO, Z. ZUBER, C. KEANE, O. HARARI, A. KENWRIGHT, R. CUTTICA, V. KELTSEV, R. XAVIER, I. CALVO, I. NIKISHINA, N. RUBIO-PÉREZ, E. ALEKSEEVA, V. CHASNYK, J. CHAVEZ, G. HORNEFF, V[IOLETTA] OPOKA-WINIARSKA, P. QUARTIER, C. SILVA, E. SILVERMAN, A. SPINDLER, A. MARTINI, D. LOVELL, H. BRUNNER. Ann. Rheum. Dis. 2013 vol. 72 suppl. 3 s. 70, Annual European Congress of Rheumatology EULAR 2013. Madrid, 12-15 June 2013. Abstr.